Senthil Sadhasivam
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Senthil Sadhasivam sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Senthil Sadhasivam: 7 sponsored US clinical trials, 5 recruiting.
Senthil Sadhasivam sponsors 7 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 1 completed. 2 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Postoperative Pain, with 2 trials.
Upper-quartile sponsor footprint
Senthil Sadhasivam sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
7 total, page 1 of 1
Evaluation of Analgesia for Cardiac Elective Surgery in Children
NCT06626035
Evaluation of Analgesia for Spine Fusion Elective Surgery in Children
NCT06626503
Personalized Perioperative Analgesia Platform (PPAP) for Cesarean Section
NCT05380531
Personalized Perioperative Analgesia Platform (PPAP) for Pediatric Spine Fusion Surgery (sIRB)
NCT05367609
Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes
NCT03923374
Personalizing Perioperative Analgesia in Children
NCT01140724
PG and PK of Oxycodone to Personalize Post-op Pain Management Following Surgery in Children
NCT03495388
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 2 |
Therapeutic Areas
Where Senthil Sadhasivam enrollment is open (later-stage tilt)
5 recruiting of 7 indexed (71% open); 1 completed (14%).
Phase mix: 2 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Postoperative Pain (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Senthil Sadhasivam: open-pipeline peers nationwide
Peers matched on 7 registered trials and 71% open enrollment, not the therapeutic-area sidebar.
Senthil Sadhasivam sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 trials (± recruiting share)
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors near 71% open enrollment (± trial volume)
- Anna Stanhewicz, PhD · 71% recruiting · 14 trials
- Glenn J. Hanna · 71% recruiting · 7 trials
- CorEvitas · 69% recruiting · 13 trials
- Revolution Medicines · 69% recruiting · 16 trials
Related
What to do with this Senthil Sadhasivam page
7 registered trials is a research-attention snapshot, not an endorsement of Senthil Sadhasivam or any single study.
- 5 of Senthil Sadhasivam's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Postoperative Pain is the condition Senthil Sadhasivam studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Postoperative Pain trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Senthil Sadhasivam pipeline card: 7 registered trials from official public datasets.Report a data error.